Explore the categories so you can find more about your search.

Categorie > Cardiovascular / Cardiology

New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored In Large Patient Registry

Categorie : Cardiovascular / Cardiology
Registry data for more than 500 patients presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting show deep vein thrombosis (DVT) treatment with the Trellis device breaks up a blood clot in most patients much quicker than using a drug alone. Using imaging, the device ...

read more Registry data for more than 500 patients presented at the Society of Interventional Radiology's 33rd Annual Scientific Meeting show deep vein thrombosis (DVT) treatment with the Trellis device breaks up a blood clot in most patients much quicker than using a drug alone. Using imaging, the device read more Tue Mar 2008 Tue Mar 2008

Breakthrough Treatment For Severe Frostbite Saves Limbs

Categorie : Cardiovascular / Cardiology
Using imaging to visualize areas lacking blood flow and deliver drugs via catheter, interventional radiologists are reopening recently frozen, clotted arteries with clot-busting and anti-spasmodic drugs. The people in a recent prospective trial had severely frostbitten hands and feet (with tissue fr ...

read more Using imaging to visualize areas lacking blood flow and deliver drugs via catheter, interventional radiologists are reopening recently frozen, clotted arteries with clot-busting and anti-spasmodic drugs. The people in a recent prospective trial had severely frostbitten hands and feet (with tissue fr read more Tue Mar 2008 Tue Mar 2008

First Patient Enrolled In SONIC I Registry Of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System

Categorie : Cardiovascular / Cardiology
OmniSonics Medical Technologies, Inc., a developer of advanced medical devices for use in the treatment of vascular disease, announced that it has enrolled its first patient in the SONIC I Clinical Registry. SONIC I is a prospective, multi-centered U.S. registry study of the company's OmniWave(TM) ...

read more OmniSonics Medical Technologies, Inc., a developer of advanced medical devices for use in the treatment of vascular disease, announced that it has enrolled its first patient in the SONIC I Clinical Registry. SONIC I is a prospective, multi-centered U.S. registry study of the company's OmniWave(TM) read more Tue Mar 2008 Tue Mar 2008

Age Could Be Modifiable Risk Factor In Heart Disease

Categorie : Cardiovascular / Cardiology
Age is currently considered an unmodifiable risk factor in thedevelopment of cardiovascular disease -- but it might not need to be.According to the authors of a Viewpoint published on March 4, 2008 inThe Lancet, age can be broken down into factorswhich are indeed"unstoppable," but also into factors ...

read more Age is currently considered an unmodifiable risk factor in thedevelopment of cardiovascular disease -- but it might not need to be.According to the authors of a Viewpoint published on March 4, 2008 inThe Lancet, age can be broken down into factorswhich are indeed read more Tue Mar 2008 Tue Mar 2008

Study Links Protein To Risk Of Heart Disease

Categorie : Cardiovascular / Cardiology
A new study published in the Journal of the American MedicalAssociation reports that there is an association between thegene for the HDL-associated protein paraoxonase 1 (PON1) and adversecardiac events such as coronary artery disease.Researcher Stanley L. Hazen, M.D., Ph.D (Cleveland Clinic) andcol ...

read more A new study published in the Journal of the American MedicalAssociation reports that there is an association between thegene for the HDL-associated protein paraoxonase 1 (PON1) and adversecardiac events such as coronary artery disease.Researcher Stanley L. Hazen, M.D., Ph.D (Cleveland Clinic) andcol read more Tue Mar 2008 Tue Mar 2008

Improved Foam For Varicose Veins Found To Be Safe In Preliminary Results From Phase II Trial

Categorie : Cardiovascular / Cardiology
A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial. The results were presented in Washington, ...

read more A small group of patients with a common heart defect who were treated for varicose veins with an injectable microfoam experienced no neurological, visual or cardiac changes as a result of the treatment, according to preliminary results from a phase II trial. The results were presented in Washington, read more Tue Mar 2008 Tue Mar 2008

NICE Guideline On Prophylaxis For Infective Endocarditis Set To Change Current Clinical Practice

Categorie : Cardiovascular / Cardiology
The National Institute for Health and Clinical Excellence (NICE) has today issued a clinical guideline on antibiotic prophylaxis against infective endocarditis (IE). In a significant change to current clinical practice, the guideline recommends that antibiotics to prevent IE should not be given to a ...

read more The National Institute for Health and Clinical Excellence (NICE) has today issued a clinical guideline on antibiotic prophylaxis against infective endocarditis (IE). In a significant change to current clinical practice, the guideline recommends that antibiotics to prevent IE should not be given to a read more Tue Mar 2008 Tue Mar 2008

Cedars-Sinai Heart Institute Now Enrolling Women With Recurrent Chest Pains For Aware Clinical Trial

Categorie : Cardiovascular / Cardiology
The Cedars-Sinai Heart Institute is recruiting female patients with recurrent chest pains who are not eligible for surgery to participate in a clinical trial studying an experimental product designed to promote blood vessel growth within the heart muscle. ...

read more The Cedars-Sinai Heart Institute is recruiting female patients with recurrent chest pains who are not eligible for surgery to participate in a clinical trial studying an experimental product designed to promote blood vessel growth within the heart muscle. read more Tue Mar 2008 Tue Mar 2008

Abbott Receives CE Mark For Smaller Size XIENCE? V Drug Eluting Stent

Categorie : Cardiovascular / Cardiology
Abbott announced that it has received CE Mark (Conformité Européene) approval for a 2.25 mm version of its XIENCE? V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of XIENCE V. The a ...

read more Abbott announced that it has received CE Mark (Conformité Européene) approval for a 2.25 mm version of its XIENCE? V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the proven efficacy, positive safety results and excellent deliverability of XIENCE V. The a read more Mon Mar 2008 Mon Mar 2008

Black Glaucoma Patients Have An Increased Risk Of Cardiovascular Disease Death, Study Finds

Categorie : Cardiovascular / Cardiology
Blacks who have been diagnosed and treated for glaucoma have an increased risk of death from cardiovascular disease, particularly those who receive certain eye drops for treatment of open-angle glaucoma, according to a study published in the March issue of Archives of Ophthalmology, Reuters reports. ...

read more Blacks who have been diagnosed and treated for glaucoma have an increased risk of death from cardiovascular disease, particularly those who receive certain eye drops for treatment of open-angle glaucoma, according to a study published in the March issue of Archives of Ophthalmology, Reuters reports. read more Mon Mar 2008 Mon Mar 2008

Family Cardiac Caregivers May Have Higher Heart Disease Risk

Categorie : Cardiovascular / Cardiology
Caring for a family member with a serious heart ailment may increase your risk of cardiac disease, according to a report presented at the American Heart Association's 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. ...

read more Caring for a family member with a serious heart ailment may increase your risk of cardiac disease, according to a report presented at the American Heart Association's 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention. read more Mon Mar 2008 Mon Mar 2008

Drinking In Middle Age And Heart Risk

Categorie : Cardiovascular / Cardiology
The Daily Mail reports that "teetotallers may finally have a reason to enjoy the odd tipple - a new [study] shows non-drinkers who begin drinking in middle-age live longer and are less likely to develop heart disease." The Daily Mirror also covers the story and says that researchers have found that ...

read more The Daily Mail reports that read more Mon Mar 2008 Mon Mar 2008

Medtronic Introduces Improvement To Minimally Invasive Treatment Of Aortic Aneurysms In Europe

Categorie : Cardiovascular / Cardiology
Continuing its record of innovation in endovascular therapies for aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced the European market launch of the Talent? Abdominal Stent Graft on the new Xcelerant® Hydro Delivery System, which features a hydrophilic coating designed to aid navigatio ...

read more Continuing its record of innovation in endovascular therapies for aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced the European market launch of the Talent? Abdominal Stent Graft on the new Xcelerant® Hydro Delivery System, which features a hydrophilic coating designed to aid navigatio read more Mon Mar 2008 Mon Mar 2008

Clinical Trial Shows Ubiquinol Has Significant Effect On Patients With Congestive Heart Failure

Categorie : Cardiovascular / Cardiology
Patients suffering from advanced congestive heart failure exhibited significantly improved heart function after supplementing with ubiquinol, according to a recent clinical trial. Ubiquinol, only available in supplement form since late 2006, is the active antioxidant form of Coenzyme Q10 (CoQ10). C ...

read more Patients suffering from advanced congestive heart failure exhibited significantly improved heart function after supplementing with ubiquinol, according to a recent clinical trial. Ubiquinol, only available in supplement form since late 2006, is the active antioxidant form of Coenzyme Q10 (CoQ10). C read more Mon Mar 2008 Mon Mar 2008

Medicare Will Continue To Provide Coverage For Heart Scan, CMS Says

Categorie : Cardiovascular / Cardiology
CMS on Wednesday said Medicare will continue to pay for a form of CT scan that can detect heart disease, despite "uncertainty regarding any potential health benefits" from the procedure, the New York Times reports. ...

read more CMS on Wednesday said Medicare will continue to pay for a form of CT scan that can detect heart disease, despite read more Mon Mar 2008 Mon Mar 2008

Boston Bans Trans Fats

Categorie : Cardiovascular / Cardiology
Health regulators in the US city of Boston, Massachusetts, have voted unanimously in favour of banning trans fats in restaurants and grocery stores, according to various media reports.A number of US cities have already taken similar steps. New York City's Board of Health, after a voluntary campaign ...

read more Health regulators in the US city of Boston, Massachusetts, have voted unanimously in favour of banning trans fats in restaurants and grocery stores, according to various media reports.A number of US cities have already taken similar steps. New York City's Board of Health, after a voluntary campaign read more Mon Mar 2008 Mon Mar 2008

Comparison Of The Commercially Available Software Used In Cardiac-Related Diagnostics

Categorie : Cardiovascular / Cardiology
For accuracy's sake, medical professionals should use the same software for comparing and analyzing diagnostic heart images taken from different time periods and laboratories, a team of researchers has concluded.The collaborative study, published in the January-February issue of the Journal of Nucle ...

read more For accuracy's sake, medical professionals should use the same software for comparing and analyzing diagnostic heart images taken from different time periods and laboratories, a team of researchers has concluded.The collaborative study, published in the January-February issue of the Journal of Nucle read more Mon Mar 2008 Mon Mar 2008

Mechanisms Suggest New Way To Treat Heart Disease Among Diabetics

Categorie : Cardiovascular / Cardiology
Researchers have discovered how diabetes, by driving inflammation and slowing blood flow, dramatically accelerates atherosclerosis, according to research to be published in the March 14 edition of the journal Circulation Research.Experts once believed that atherosclerosis, or hardening of the arteri ...

read more Researchers have discovered how diabetes, by driving inflammation and slowing blood flow, dramatically accelerates atherosclerosis, according to research to be published in the March 14 edition of the journal Circulation Research.Experts once believed that atherosclerosis, or hardening of the arteri read more Mon Mar 2008 Mon Mar 2008

Lilly Offers Helping Hand In Fight Against Chronic Disease

Categorie : Cardiovascular / Cardiology
Eli Lilly and Company recently unveiled a small tool aimed at battling a big problem - chronic disease. Lilly's free pocket-sized health book, A Healthy You! - America's Guide to Healthy Living, puts useful tips and resources in the hands of Americans to help them lead a healthy life and prevent chr ...

read more Eli Lilly and Company recently unveiled a small tool aimed at battling a big problem - chronic disease. Lilly's free pocket-sized health book, A Healthy You! - America's Guide to Healthy Living, puts useful tips and resources in the hands of Americans to help them lead a healthy life and prevent chr read more Mon Mar 2008 Mon Mar 2008

The Lancet Publishes Results From World's First Clinical Trial Of A Fully Bioabsorbable Drug Eluting Coronary Stent

Categorie : Cardiovascular / Cardiology
Data published in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (retreatment of a diseased lesion), and a low ...

read more Data published in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (retreatment of a diseased lesion), and a low read more Mon Mar 2008 Mon Mar 2008

1 | 2 | 3 | 4 next >>>